Neglected tropical diseases (NTDs) have devastating impacts on health and socioeconomic development.
Many NTDs result in disfigurement and disability, causing stigma, and discrimination; others are lethal without timely diagnosis and treatment, or are responsible for chronic morbidity.
Despite their medical diversity, NTDs share common features. They co-exist in the poorest areas of the world and disproportionately affect politically marginalized populations. Due to low visibility they have been largely overlooked by the global health community, including by drug and diagnostic developers who question the profitability of investments into research and development.
There is a serious need for readily available, easy to use, reliable and low cost diagnostics for NTDs. These tools are critical for identifying infected patients, and for detecting re-emergence, guiding delivery of appropriate control measures, and monitoring the impact of interventions. Better understanding and quality-assured use of existing tools is also essential.
In recognition of these needs, FIND focuses on a select number of priority NTDs and provides broader support to the rest. This includes assisting in defining target product profiles and facilitating access to biological materials to enable development of new diagnostics.